Company Filing History:
2 out of 22 
1 out of 832,912 Years Active: 2000-2016
Title: The Innovations of Marcia M Nizzari
Introduction
Marcia M Nizzari, an accomplished inventor based in Needham, MA, has made significant contributions to the field of genetic research and testing. With a portfolio of three patents, her work focuses on innovative methods for describing genetic variants and polymorphisms, enhancing the understanding and treatment of genetic disorders.
Latest Patents
One of her notable inventions is a Variant Database. This innovative system and method describe polymorphisms or genetic variants using information about mutations and their interrelations. By employing object-oriented concepts, variants are treated as variant objects, with relationships represented as variant relation objects. Each of these objects is an instance of an abstract class of genomic features, capable of containing multiple other objects. This approach allows for the association of genetic information and disorders with the pathogenic variants, and genetic test results can be utilized to access these objects for comprehensive reporting on a patient's genetic makeup.
Career Highlights
Marcia Nizzari has worked with Good Start Genetics, Inc., where she has applied her deep knowledge of genetics to drive advancements in the understanding of hereditary conditions. Her experience in the industry allows her to blend theoretical insights with practical applications, leading to impactful innovations.
Collaborations
Throughout her career, Marcia has collaborated with esteemed professionals such as Benjamin H Breton and David L Tefft. These partnerships have fostered a dynamic environment for innovation and enhanced her contributions to the field of genetic research.
Conclusion
Marcia M Nizzari stands out as a pioneering inventor who has significantly advanced the understanding of genetic polymorphisms through her innovative patents. Her dedication to research and collaboration continues to pave the way for advancements in genetic testing and the potential treatment of genetic disorders.